Skip to main content
I

iollo

Iollo provides an AI platform, Quinn, that unifies computational R&D pipelines for biopharma, accelerating target identification through IND-enabling stages. The platform offers transparent analysis and runs securely within the client's environment, significantly reducing R&D timelines. Additionally, the company offers a clinical-grade metabolomics panel for consumers to track over 600 metabolites related to health markers like inflammation and aging.

San Francisco, United StatesFounded 202251K+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Traditional blood tests often provide a limited snapshot of an individual's health, typically measuring only a small number of biomarkers and requiring inconvenient visits to clinical labs. This can result in a fragmented understanding of metabolic health and hinder proactive wellness management.

Solution

iollo offers at-home blood test kits that empower individuals to gain comprehensive insights into their metabolic health through the analysis of over 500 biomarkers. Using a CE-marked and FDA-registered microsample collection device, users can conveniently collect blood samples from home without the need for requisition forms or lab visits. The collected samples are then sent to iollo's laboratory for advanced mass spectrometry analysis, and state-of-the-art AI algorithms generate personalized health reports and recommendations. These reports provide actionable insights into various health areas, including biological age, metabolic function, heart health, and gut microbiome health, enabling users to track and improve their overall wellness.

Target Audience

iollo is designed for individuals seeking to proactively manage their health and wellness through comprehensive insights into their blood metabolome, including those interested in weight loss, improved energy levels, and understanding the impact of lifestyle choices on their health.

Features

  • At-home blood collection using a CE-marked and FDA-registered microsampling device
  • Analysis of over 500 metabolite biomarkers, including amino acids, hormones, lipids, and vitamins
  • Personalized health reports generated using advanced mass spectrometry and AI algorithms
  • Insights into key health areas such as biological age, metabolic health, heart health, and gut microbiome health
  • Identification of foods, supplements, and lifestyle habits that can positively impact long-term health
  • Tracking of biomarker trends to monitor the impact of lifestyle changes
  • Secure, HIPAA-compliant data handling with encryption of protected health information
This profile is AI-generated and may contain inaccuracies.